Literature DB >> 15040031

Establishment of Helicobacter pylori infection model in Mongolian gerbils.

Jie Yan1, Yi-Hui Luo, Ya-Fei Mao.   

Abstract

AIM: To establish a stable and reliable model of Helicobacter pylori infection model in Mongolian gerbils and to observe pathological changes in gastric mucosa in infected animals.
METHODS: Mongolian gerbils were randomly divided into 18 groups; 6 groups were infected with H pylori clinical strain Y06 (n=6, groups Y), 6 groups were infected with H pylori strain NCTC11637 (n=6, groups N), and 6 uninfected groups as negative controls (n=4, groups C). H pylori suspensions at the concentrations of 2X10(8) and 2X10(9) CFU/mL of strain NCTC11637 and strain Y06 were prepared. The animals in three groups N and in three groups Y were orally challenged once with 0.5 mL of the low concentration of the bacterial suspension. The animals in another three groups N and in another three groups Y were orally challenged with 0.5 mL of the high concentration of the bacterial suspension for 3 times at the intervals of 24 h, respectively. For the negative controls, the animals in six groups C were orally given with the same volume of Brucella broth at the corresponding inoculating time. The animals were killed after 2nd, 4(th) and 6(th) week after the last challenge and the gastric mucosal specimens were taken for urease test, bacterial isolation, pathological and immunohistochemical examinations.
RESULTS: Positive isolation rates of H pylori in the animals of groups Y at the 2nd, 4(th) and 6(th) week after one challenge were 0%, 16.7% and 66.7%, while in the animals of groups N were 0%, 0% and 16.7%, respectively. Positive isolation rates of H pylori in the animals of groups Y at the 2nd, 4(th) and 6(th) week after three challenges were 66.7%, 100% and 100%, while in the animals of groups N were 66.7%, 66.7% and 100%, respectively. In animals with positive isolation of H pylori, the bacterium was found to colonized on the surface of gastric mucosal cells and in the gastric pits, and the gastric mucosal lamina propria was infiltrated with inflammatory cells.
CONCLUSION: By using H pylori suspension at high concentration of 2X10(9) CFU/mL for multiple times, the orally challenged Mongolian gerbils can be used as a stable and reliable H pylori infection model. The 2 strains of H pylori can colonize in gastric mucosa of the infected animals and cause mild inflammation reaction.

Entities:  

Mesh:

Year:  2004        PMID: 15040031      PMCID: PMC4727002          DOI: 10.3748/wjg.v10.i6.852

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

1.  Expression of lung resistance protein in patients with gastric carcinoma and its clinical significance.

Authors:  Zhong-Min Liu; Nan-Hai Shou; Xi-Hong Jiang
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Fish sauce and gastric cancer:an ecological study in Fujian Province,China.

Authors:  Lin Cai; Shun-Zhang Yu; Wei-Min Ye; Ying-Nan Yi
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

3.  Methionine-dependence and combination chemotherapy on human gastric cancer cells in vitro.

Authors:  Wei-Xin Cao; Jing-Min Ou; Xu-Feng Fei; Zheng-Gang Zhu; Hao-Ran Yin; Min Yan; Yan-Zhen Lin
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Differential display of vincristine-resistance-related genes in gastric cancer SGC7901 cell.

Authors:  Xin Wang; Mei Lan; Yong-Quan Shi; Ju Lu; Yue-Xia Zhong; Han-Ping Wu; Hui-Hong Zai; Jie Ding; Kai-Cun Wu; Bo-Rong Pan; Jian-Ping Jin; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

5.  Overexpression of cyclin E in Mongolian gerbil with Helicobacter pylori-induced gastric precancerosis.

Authors:  Yong-Li Yao; Bo Xu; Yu-Gang Song; Wan-Dai Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

6.  Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens.

Authors:  Jacqueline I Keenan; Sjoerd G Rijpkema; Zarmina Durrani; Justin A Roake
Journal:  FEMS Immunol Med Microbiol       Date:  2003-05-25

7.  Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils.

Authors:  T Ohkusa; I Okayasu; H Miwa; K Ohtaka; S Endo; N Sato
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

8.  The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.

Authors:  B-S Sheu; J-J Huang; H-B Yang; A-H Huang; J-J Wu
Journal:  Aliment Pharmacol Ther       Date:  2003-05-15       Impact factor: 8.171

9.  Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent.

Authors:  Christine A Garhart; Frederick P Heinzel; Steven J Czinn; John G Nedrud
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

Review 10.  Review article: Helicobacter pylori and reflux disease.

Authors:  P Sharma; N Vakil
Journal:  Aliment Pharmacol Ther       Date:  2003-02       Impact factor: 8.171

View more
  3 in total

1.  Helicobacter pylori strain-specific modulation of gastric inflammation in Mongolian gerbils.

Authors:  Ken Ohnita; Hajime Isomoto; Shoji Honda; Akihiro Wada; Chun-Yang Wen; Yoshito Nishi; Yohei Mizuta; Toshiya Hirayama; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

Review 2.  Animal Models and Helicobacter pylori Infection.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

3.  Phosphorylation of phosphatase and tensin homolog induced by Helicobacter pylori promotes cell invasion by activation of focal adhesion kinase.

Authors:  Zhen Yang; Ximei Cao; Wenting Xu; Chuan Xie; Jiang Chen; Yin Zhu; Nonghua Lu
Journal:  Oncol Lett       Date:  2017-11-16       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.